Hikma Pharmaceuticals PLC

BMV:HIK N Stock Report

Market Cap: Mex$83.8b

Hikma Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:HIK N Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Nov 25BuyMex$203,153,851Said Samih DarwazahIndividual530,000Mex$391.78
06 Nov 25BuyMex$123,169,697Mazen Samih DarwazahIndividual315,000Mex$392.53
16 Sep 25BuyMex$5,610,148Mazen Samih DarwazahIndividual14,000Mex$400.72
07 Aug 25BuyMex$88,143,685Mazen Samih DarwazahIndividual200,000Mex$440.72
06 Jun 25SellMex$21,807,131Bassam Wael KanaanIndividual40,000Mex$545.18

Insider Trading Volume

Insider Buying: HIK N insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HIK N?
Owner TypeNumber of SharesOwnership Percentage
State or Government00%
Public Companies60,0000.0271%
Employee Share Scheme839,6490.379%
Individual Insiders5,699,8182.57%
General Public20,318,8409.18%
Private Companies60,672,66427.4%
Institutions133,860,95560.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.1%
Darhold Ltd.
60,000,000Mex$22.7b0%no data
6.17%
Boston Partners Global Investors, Inc.
13,666,938Mex$5.2b20.1%0.14%
5.7%
BlackRock, Inc.
12,633,799Mex$4.8b-0.65%no data
3.53%
The Vanguard Group, Inc.
7,821,549Mex$3.0b0.7%no data
3.12%
Bank Julius Bär & Co. AG
6,906,640Mex$2.6b1.29%0.34%
2.51%
UBS Asset Management AG
5,549,517Mex$2.1b-6.27%0.01%
1.95%
HSBC Global Asset Management (UK) Limited
4,317,937Mex$1.6b15.4%0.03%
1.93%
Jupiter Fund Management Plc
4,263,156Mex$1.6b117%0.24%
1.62%
Baillie Gifford & Co.
3,582,348Mex$1.4b-4.41%0.03%
1.48%
Royal London Asset Management Ltd.
3,286,488Mex$1.2b2.8%0.09%
1.34%
Polar Capital Holdings Plc
2,978,216Mex$1.1b7.79%0.18%
1.3%
Columbia Management Investment Advisers, LLC
2,885,714Mex$1.1b2.39%0.01%
1.22%
Invesco Ltd.
2,712,287Mex$1.0b-15.3%0.01%
1.22%
Schroder Investment Management Limited
2,699,622Mex$1.0b2.48%0.03%
1.11%
Amundi Asset Management SAS
2,450,968Mex$927.4m-15.9%0.01%
1.02%
Fidelity International Ltd
2,256,293Mex$853.8m26.3%0.02%
0.98%
State Street Global Advisors, Inc.
2,173,575Mex$822.5m-0.08%no data
0.92%
Aviva Investors Global Services Ltd.
2,039,990Mex$771.9m-1.58%0.05%
0.87%
Mazen Samih Darwazah
1,925,837Mex$728.7m18.5%no data
0.85%
Dimensional Fund Advisors LP
1,875,108Mex$709.5m3.49%0.01%
0.75%
Legal & General Investment Management Limited
1,653,735Mex$625.8m-1.69%0.01%
0.73%
American Century Investment Management Inc
1,624,420Mex$614.7m-12.7%0.01%
0.72%
Nordea Investment Management, AB
1,603,953Mex$606.9m18.3%0.02%
0.66%
Van Lanschot Kempen Investment Management N.V.
1,471,489Mex$556.8m57%0.18%
0.64%
Aberdeen Group Plc
1,423,944Mex$538.8m6.55%0.02%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/20 05:56
End of Day Share Price 2025/09/05 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hikma Pharmaceuticals PLC is covered by 28 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon MatherBarclays
Sidhartha ModiBarclays
Emily FieldBarclays